Produktname:tert-butyl N-(4-methylpiperidin-4-yl)carbamate
IUPAC Name:tert-butyl N-(4-methylpiperidin-4-yl)carbamate
- CAS:163271-08-7
- Molekulare Formel:C11H22N2O2
- Reinheit:95%+
- Katalognummer:CM103826
- Molekulargewicht:214.31
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:163271-08-7
- Molekulare Formel:C11H22N2O2
- Schmelzpunkt:-
- SMILES-Code:CC(C)(C)OC(=O)NC1(C)CCNCC1
- Dichte:
- Katalognummer:CM103826
- Molekulargewicht:214.31
- Siedepunkt:308°C at 760 mmHg
- Mdl-Nr.:MFCD08703167
- Lagerung:Store at 2-8°C.
Category Infos
- Piperidines
- Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
- Piperidine,Piperidine Price
- if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Column Infos
- Darovasertib
- The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Darovasertib, a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma”. Uveal melanoma (UM) is the most common primary intraocular malignancy. About half of primary uveal melanoma tumors metastasize but with no standard treatment. Most patients with metastatic uveal melanoma have been found to have mutations in GNAQ or GNA11, that are associated with consistent activation of the protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) pathways.
IDEAYA's Darovasertib (IDE196) is a potent, selective small molecule inhibitor of PKC which stops activating PKC/MEK pathway. Darovasertib is under Phase 2 expansion and Phase 3 registrational trial with Crizotinib in GNAQ/11 metastatic cutaneous melanoma.